CG
ARGS

Cutler Group’s Argos Therapeutics, Inc. ARGS Stock Holding History

Cutler Group’s Portfolio ARGS Stock Details ARGS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-95
Closed – – 6744
2017
Q3 		$0 Sell
95
-740
-89% -$3.55K ﹤0.01% 7448
2017
Q2 		$6K Buy
835
+190
+29% +$1.62K ﹤0.01% 4775
2017
Q1 		$5K Buy
645
+640
+12,800% +$40.5K ﹤0.01% 4837
2016
Q4 		$0 Sell
5
-85
-94% -$7.95K ﹤0.01% 8061
2016
Q3 		$8K Hold
90
– – ﹤0.01% 4544
2016
Q2 		$11K Buy
+90
New +$12K ﹤0.01% 4087

Other funds holding ARGS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
PI
Pharmstandard International Luxembourg $29M AUM 3.25% 1-Year Est. Return
SMH
Sanders Morris Harris Houston, Texas $172M AUM 22.54% 1-Year Est. Return
WS
Wedbush Securities Los Angeles, California $3.43B AUM 24.13% 1-Year Est. Return
KeyBank National Association
KeyBank National Association Cleveland, Ohio $27.4B AUM 24.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return

Cutler Group's ARGS Position: Q4 2017 in Review

Cutler Group sold out of Argos Therapeutics, Inc. (ARGS) in Q4 2017, closing a stake of 95 shares.

Cutler Group first reported a position in ARGS in Q2 2016 and held it in 6 quarters. The position peaked at $11K in Q2 2016. 28 funds tracked by Wall St. Rank hold ARGS as of Q4 2017.

  • Cutler Group reported no remaining Argos Therapeutics, Inc. position as of Q4 2017 after selling out during the quarter.
  • Cutler Group sold 95 Argos Therapeutics, Inc. shares in Q4 2017.
  • Cutler Group first reported a position in Argos Therapeutics, Inc. in Q2 2016 and held it in 6 quarters.
  • Cutler Group's Argos Therapeutics, Inc. position peaked at $11K in Q2 2016.
  • 28 funds tracked by Wall St. Rank held Argos Therapeutics, Inc. as of Q4 2017.

Based on Cutler Group's 13F filing for Q4 2017, filed 17 Jan 2018.